The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer.
 
David Dewei Yang
No Relationships to Disclose
 
Vinayak Muralidhar
No Relationships to Disclose
 
Brandon Arvin Virgil Mahal
No Relationships to Disclose
 
Marie Vastola
No Relationships to Disclose
 
Ninjiin Boldbaatar
No Relationships to Disclose
 
Shelby A Labe
No Relationships to Disclose
 
Michelle Daniel Nezolosky
No Relationships to Disclose
 
Neil E. Martin
Consulting or Advisory Role - Via Oncology
 
Martin T. King
No Relationships to Disclose
 
Kent William Mouw
No Relationships to Disclose
 
Peter F Orio
No Relationships to Disclose
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - alligent; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Eisai; Exelixis; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Peloton Therapeutics; Pfizer; Prometheus; Roche/Genentech
Research Funding - Agensys (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - advisory boards/consultancy
 
Quoc-Dien Trinh
No Relationships to Disclose
 
Paul L. Nguyen
Stock and Other Ownership Interests - Volatilyx (I)
Consulting or Advisory Role - Astellas Pharma; Augmenix; Bayer; Biogen (I); Dendreon; Ferring; GenomeDx; GigaGen (I); Infinity Pharmaceuticals (I); Medivation; Nanobiotix
Research Funding - Astellas Pharma; Janssen; Nanobiotix; Wako Diagnostics (I)
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
Travel, Accommodations, Expenses - Ferring